|1.||Nakajima, Takero: 6 articles (07/2015 - 12/2007)|
|2.||Kamijo, Yuji: 6 articles (07/2015 - 12/2007)|
|3.||Aoyama, Toshifumi: 6 articles (07/2015 - 12/2007)|
|4.||Kyogashima, Mamoru: 5 articles (07/2015 - 12/2007)|
|5.||Hara, Atsushi: 5 articles (01/2012 - 12/2007)|
|6.||Pérez, Rolando: 5 articles (01/2012 - 01/2005)|
|7.||Han, Xianlin: 5 articles (08/2010 - 08/2002)|
|8.||Aubourg, Patrick: 4 articles (09/2014 - 01/2006)|
|9.||Sevin, Caroline: 4 articles (09/2014 - 01/2006)|
|10.||Hernández, Ana María: 4 articles (01/2012 - 01/2005)|
|1.||Metachromatic Leukodystrophy (Sulfatide Lipidosis)
02/01/1965 - "STRUCTURAL STUDIES ON SULFATIDES IN METACHROMATIC LEUKODYSTROPHY."
06/10/2014 - "Quantification of sulfatides in dried blood and urine spots from metachromatic leukodystrophy patients by liquid chromatography/electrospray tandem mass spectrometry."
03/30/2014 - "Ultra-performance liquid chromatography/tandem mass spectrometry for determination of sulfatides in dried blood spots from patients with metachromatic leukodystrophy."
10/21/2013 - "Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy."
01/01/2012 - "Metachromatic leukodystrophy (MLD) is a recessive autosomal disease which is characterized by an accumulation of sulfatides in the central and peripheral nervous system. "
09/01/2012 - "However, the amount of sulfatides in well-differentiated tumors was significantly greater than that in poorly differentiated tumors, which was confirmed by thin-layer chromatography and immunostaining with a monoclonal antisulfatide antibody. "
01/01/2004 - "To investigate the expression of sulfatides in the tissue homogenates of malignant ovarian tumors, benign ovarian tumors, and control tissues and to study the relation between this marker and other clinico-pathological criteria such as the tumor type, grade of differentiation, surgical stage and ovulatory years. "
01/01/2013 - "Importantly, changes in cellular sulfatide levels as well as circulating sulfatides in serum directly impact cardiovascular and cancer disease development and progress. "
01/01/2004 - "Sulfatides may play a role in the pathogenesis of benign and malignant ovarian tumors. "
01/01/2004 - "Sulfatides were significantly higher in patients with more ovulatory years and tumors of advanced stages (stage III/IV) and poor differentiation. "
08/01/2002 - "The findings demonstrate that a marked decrease in sulfatides is associated with AD pathology even in subjects with very mild dementia and that these changes may be linked with early events in the pathological process of AD."
07/01/2003 - "We recently noted a profound decline in brain sulfatides (ST) in subjects who died with incipient dementia due to Alzheimer's disease. "
08/01/2002 - "The results demonstrate that: (i) sulfatides were depleted up to 93% in gray matter and up to 58% in white matter from all examined brain regions from AD subjects with very mild dementia, whereas all other major classes of lipid (except plasmalogen) in these subjects were not altered in comparison to those from age-matched subjects with no dementia; (ii) there was no apparent deficiency in the biosynthesis of sulfatides in very mild AD subjects as characterized by the examination of galactocerebroside sulfotransferase activities in post-mortem brain tissues; (iii) the content of ceramides (a class of potential degradation products of sulfatides) was elevated more than three-fold in white matter and peaked at the stage of very mild dementia. "
01/01/2002 - "The activities of several lysosomal enzymes involved in catabolism of gangliosides and sulfatides were measured in leukocytes from subjects with dementia of the Alzheimer type, DS, and age-matched controls, by fluorimetry and spectrophotometry using specific substrates. "
07/01/1995 - "These data indicate that sulfatides have significant in vivo protective effects in neutrophil and selectin-dependent models of lung injury."
07/01/1995 - "Naturally occurring sulfatide, synthetic sulfatides and sulfated ganglioside were highly protective against lung injury following systemic activation of complement. "
07/01/1995 - "The protective effects of synthetic sulfatides required sulfation of galactose in position 3. Sulfatide was also protective in the IgG immune complex model of lung injury. "
08/01/2008 - "We excluded the possibility that the supplementation of sulfatides and/or apoE altered the production of Abeta peptides from H4-APPwt cells through determination of the clearance of Abeta peptides from conditioned H4-APPwt cell media by neuroblastoma cells which do not appreciably generate Abeta peptides. "
|1.||Cerebroside-Sulfatase (Arylsulfatase A)
|2.||Immunoglobulin G (IgG)
|4.||Apolipoproteins E (ApoE)
|6.||Complement System Proteins (Complement)
|7.||Antigen-Antibody Complex (Immune Complex)
|2.||Renal Dialysis (Hemodialysis)
|3.||Heterologous Transplantation (Xenotransplantation)